Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION...
Filed by Mylan N.V. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-6(b) un...
Filed by Mylan N.V. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to...
Mylan to Present at the 2020 RBC Capital Markets' Virtual Global Healthcare Conference PR Newswire HERTFORDSHIR...
By Micah Maidenberg Mylan NV said Tuesday it struck a deal to license remdesivir, a therapy that may treat patients with Covid-19, from Gilead...
Filed by Mylan N.V. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-6(b) under...
Mylan to Supply Investigational Antiviral Remdesivir for the Potential Treatment of COVID-19 Mylan and Gilead...
Filed by Mylan N.V. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed...
false--12-31Q1202000016236131.001.001.001.001.001.001.001.001.001.001.0000.01120000000012000000000.0030.00...
false0001623613 0001623613 2020-05-11 2020-05-11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON...
Mylan Reports First Quarter 2020 Results and Reaffirms 2020 Guidance PR Newswire HERTFORDSHIRE, England and...
Mylan to Present at the BofA Securities Virtual Health Care Conference 2020 PR Newswire HERTFORDSHIRE, England...
Mylan Releases "A Legacy of Impact: 2019 Global Social Responsibility Report" Comprehensive report includes a look at Mylan's...
P70001623613true2019FY--12-31 0001623613 2019-01-01 2019-12-31 0001623613 2019-12-31 0001623613 2019-06-30 0001623613 2020-04-24 iso4217:USD...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.